As of Friday close, Fresenius Medical Care AG & Co. KGaA’s (NYSE:FMS) stock was down -$0.29, moving down -1.19 percent to $24.07. The average number of shares traded per day over the past five days has been 416,880 shares. 2 times new highs have been achieved over the past 5 days, with a -$2.02 fall in that time frame. In the last twenty days, the average volume was 391,785, while in the previous 50 days, it was 483,648.
Since last month, FMS stock retreated -12.66%. Shares of the company fell to $24.00 on 08/18/23, the lowest level in the past month. A 52-week high of $27.72 was reached on 07/20/23 after having rallying from a 52-week low of $12.78. Since the beginning of this year, FMS’s stock price has risen by 47.31% or $7.73, and marked a new high 35 times. However, the stock has declined by -13.15% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Right now, Fresenius Medical Care AG & Co. KGaA (FMS) has a P/E ratio of about 20.75. The stock’s beta is 1.06.
The latest dividend of $0.7086 per share was paid out, which is -0.1% less than last year’s $0.7093. On Wednesday May 3 2023, a $0.0007 dividend decrease was announced.
Financial Health
Based on annual data, FMS earned $5.59 billion in gross profit and brought in $20.44 billion in revenue.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. FMS’s revenue rose 9.17% during the quarter, while net income inched up to $21.73 billion. While analysts expected Fresenius Medical Care AG & Co. KGaA to report $0.3 quarterly earnings, the actual figure was $0.32 per share, beating the consensus estimate by 6.70%. During the quarter, the company generated $869.75 million in EBITDA. The liabilities of Fresenius Medical Care AG & Co. KGaA were 21.84 billion at the end of its most recent quarter ended June 29, and its total debt was $13.07 billion.
Technical Picture
This quick technical analysis looks at Fresenius Medical Care AG & Co. KGaA’s (FMS) price momentum. With a historical volatility rate of 29.72%, the RSI 9-day stood at 26.14% on 18 August.
With respect to its five-day moving average, the current Fresenius Medical Care AG & Co. KGaA price is down by -7.74% percent or -$2.02. At present, FMS shares trade -11.02% below its 20-day simple moving average and +15.89% percent above its 100-day simple moving average. However, the stock is currently trading approximately +5.66% above its SMA50 and +73.54% above its SMA200.
Stochastic coefficient K was 2.91% and Stochastic coefficient D was 5.84%, while ATR was 0.49. Given the Stochastic reading of 2.58% for the 14-day period, the RSI (14) reading has been calculated as 35.32%. As of today, the MACD Oscillator reading stands at -0.84, while the 14-day reading stands at -1.04.
Analyst Ratings
Fresenius Medical Care AG & Co. KGaA downgraded its rating on Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) to a Neutral in a note to investors on August 14, 2023. The analysts firm previously had a Buy rating on the stock.Fresenius Medical Care AG & Co. KGaA (FMS) has been rated Hold by analysts. According to 5 brokerage firms, FMS is a sell, and 10 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 1 analyst rate Fresenius Medical Care AG & Co. KGaA stock as buy, with 4 recommending it as overweight.
With a median target price of $24.15, the current consensus forecast for the stock is $13.08 – $31.69. Based on these forecasts, analysts predict Fresenius Medical Care AG & Co. KGaA (FMS) will achieve an average price target of $23.77.
